A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

Name: A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
Published: 2023
License: Public Domain

Memorial Sloan Kettering Cancer Center · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

sickle-cell-disease

sickle cell disease, thalassemia, beta, thalassemia, allogeneic hematopoietic cell transplantation, beta thalassemia, 23-009, memorial sloan kettering cancer center, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

Related documents